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Abstract 
 
Protein tyrosine phosphatase 1B (PTP1B) regulates various signalling pathways including 
insulin, leptin, IGF-1 and growth hormone (GH) signalling. Transmission of the GH signal 
depends on JAK2, which is how PTP1B is thought to modulate GH signalling in the liver, 
based on studies utilising global PTP1B knockout mice (Ptp1b-/-). Here, we investigated the 
liver-specific role of PTP1B in GH signalling, using liver-specific Ptp1b-/- mice (alb-crePtp1b- 
/-), under physiological (chow) or insulin resistant (high-fat diet (HFD)) feeding conditions. 
 
Body weight and adiposity were comparable between female alb-crePtp1b-/- and Ptp1bfl/fl 
control mice. On chow diet, under 48-hour fasting GH-resistant conditions, GH stimulation in 
vivo led to a robust stimulation of the JAK-STAT signalling pathway. Alb-crePtp1b-/- mice 
exhibited significantly higher GH-induced JAK2 phosphorylation and SOCS3 gene expression 
post-GH stimulation. However, STAT3, STAT5 and ERK1/2 phosphorylation and SOCS2 
gene expression were similar between groups. Interestingly, GH-induced mTOR 
phosphorylation was significantly higher in alb-crePtp1b-/- mice 5-min post-GH stimulation 
compared to controls, revealing this part of the pathway under direct control of PTP1B. Under 
ad lib HFD-fed conditions, GH-induced STAT5 phosphorylation significantly increased in alb- 
crePtp1b-/- mice only, with no alterations in the controls. Overall, our data demonstrate that 
liver-specific PTP1B deletion leads to significant alterations in GH signalling with increased 
phosphorylation of JAK2, STAT5 and mTOR phosphorylation and SOCS3 gene expression. 
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Introduction 
 
Human growth hormone (hGH) is an important metabolic hormone which has effects 
on glucose, protein and lipid metabolism [1, 2] Secondary consequences such as increased 
adiposity and insulin resistance can occur in individuals suffering with abnormal hGH secretion 
[1, 3]. Thus it is important to understand the regulators of growth hormone signalling in vivo. 
Initial events in growth hormone signalling include homodimerization of the GH receptor 
(GHR), recruitment of Janus kinase 2 (JAK2) to the cytoplasmic domain of the receptor, and 
activation of JAK2 via autophosphorylation [4, 5]. Various signalling proteins are then recruited 
to high affinity binding sites on tyrosine phosphorylated JAK2 and GHR which leads to the 
activation of signal transducers and activators of transcription (STATs) 1, 3, and 5b, and several 
other pathways including Ras-MAP and IRS-1/PI3K/Akt [2, 5]. 
The mechanisms terminating GHR signalling are less well understood. A study in 2003, 
identified protein tyrosine phosphatase 1B (PTP1B) as a negative regulator of growth hormone 
signalling, using livers from globally-deficient PTP1B knockout mice [6]. An absence of PTP1B 
resulted in GH-dependent hyper-phosphorylation of JAK2 and enhanced activation of STAT3 
and STAT5 [6]. However, since this study examined PTP1B deletion in globally-deficient mice, 
which exhibit decreased body weight under high-fat diet (HFD) feeding conditions, it is unclear 
whether the effects on GH signalling were specifically caused by PTP1B deletion in the liver. 
In order to determine the specific role of liver-PTP1B in GH signalling [6], phosphorylation  
of the JAK-STAT pathway and downstream signalling targets were assessed in adult, female 
chow-   and  HFD-fed   liver-specific  knockout  mice   (alb-crePtp1b-/-),   following  a   hGH 
stimulation time course under ad lib-fed and 48-hour fasted states (to induce GH resistance). 
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Materials and methods 
 
Ethics statement. All animal procedures were approved by the University of Aberdeen 
Ethics Review Committee Board and performed under a project license approved by the Home 
Office under the Animals (Scientific Procedures) Act 1986 (PPL60/3951). 
Animal studies. Female Ptp1bfl/fl mice and alb-crePtp1b-/- mice expressing Cre 
recombinase under the control of the serum albumin promoter were described previously [7]. 
DNA extraction and genotyping for the Ptp1b floxed allele and the presence of Cre by PCR 
were performed as described previously [8]. Mice studied were age-matched littermates, which 
were generated on a C57BL/6 background. Mice were housed in groups and maintained at 22- 
24ºC on a 12-h light/dark cycle with free access to food and water. At weaning (~21 days), 
mice were placed on standard 3.4% fat chow pellet diet (Rat and Mouse Breeder and Grower, 
Special Diets Services, DBM, Scotland) or HFD (Adjusted Calories Diet, 55 % fat, Harlan 
Teklad, USA) and weight was recorded every two weeks. The approximate fatty acid profile 
of Adjusted Calories Diet (% total fat) was 28% saturated, 30% trans, 28% monounsaturated 
(cis) and 14% polyunsaturated (cis), as described previously [9]. For signalling studies, chow- 
or HFD-fed female alb-crePtp1b-/- and Ptp1bfl/fl mice were injected with saline or 1 µg/g body 
weight hGH. Mice were either fasted for 48-hours (to induce GH resistance) or used ad lib fed. 
Mice were sacrificed by cervical dislocation at 0, 5, 10, 30 and 90 min. Mice in the 0 min group 
were injected with saline. Tissues were dissected immediately and frozen in liquid nitrogen. 
Body composition using dual-energy X-ray absorptiometry (DXA). The DXA 
instrument used was the Lunar PIXIMUS-Densitometer (GE Medical Systems, USA). DXA 
scans and analyses were carried out as instructed by the manufacturer. A quality control 
phantom mouse was scanned daily before samples were scanned. The phantom and samples 
were mounted on an adhesive disposable plastic tray placed on the imaging surface. Mice were 
anesthetised with isoflurane (1.5-2.0% with 2 l/min O2). Mice were then spread out on the 
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adhesive trays in the prostrate position with limbs extended away from the body. Mouse tails 
were not measured. As recommended by the manufacturer, a region of interest (ROI) was 
created to exclude the head from analyses. 
Immunoblotting. Tissue lysates were prepared in RIPA buffer containing fresh sodium 
orthovanadate and protease inhibitors, as described previously [10]. Proteins were separated by 
4-12% SDS-PAGE and transferred to nitrocellulose membranes. Immunoblots were performed 
using antibodies from Cell Signaling (Cell Signaling by NEB, Hitchin, UK) (unless stated 
otherwise) against PTP1B (Millipore), SHP2 (Santa Cruz), pJAK2 Y1007/1008 (Invitrogen), 
JAK2, pSTAT3 Y705, STAT3, pSTAT5 Y694/699, STAT5, pERK1/2 MAPK T202/Y204, p- 
FRAP/p-mTOR S2448 (Santa Cruz), mTOR, pS6 ribosomal protein S235/236, S6 ribosomal 
protein, Akt/PKB (Santa Cruz) and IRβ (Santa Cruz). Immunoblots were developed using 
horseradish peroxidase-conjugated secondary antibodies, visualised using enhanced 
chemiluminescence, and quantified by densitometry scanning with Image J or Bio1D software 
(PeqLab, Fareham, UK). 
Gene expression analysis. Total RNA was isolated from mouse liver using TRI Reagent 
(Ambion, Warrington UK), according to the manufacturer’s protocol. First strand cDNA was 
synthesized from 1 µg of total RNA employing the Bioline Bioscript™ Pre-amplification 
System and oligo(dT)12-18. Two (2) μl of diluted cDNA (1:10) was used to amplify target genes 
by real-time RT-PCR (10 μl), using GoTaq qPCR Master Mix (Promega, Southampton, UK). 
The Roche LightCycler® 480 System (Roche Diagnostics, Burgess Hill, UK) was used for 
analysis. Relative gene expression was calculated using the comparative Ct (2−ΔΔCt) method. 
A geometric mean of three commonly used reference genes; hypoxanthine-guanine 
phosphoribosyltransferase (Hprt), 18S ribosomal RNA (18S) and Glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh) were used to normalise data. A geometric mean of the relative copy 
numbers of mouse PCRs were followed by melting curves (70-95°C). 
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Data analysis. Data are expressed as mean ± SEM and n represents the number of mice or 
biological replicates. Statistical analyses were performed using one-way ANOVA with 
Tukey’s multiple comparison post-tests, repeated measures two-way ANOVA with Bonferroni 
multiple comparisons post-tests or two-tailed Student’s t-tests, as appropriate. The critical 
alpha level (P) was set at 0.05. P < 0.05 was considered statistically significant. GraphPad 
Prism 5 statistical software was used for analyses. 
 
 
Results 
 
Liver-PTP1B deletion has no effect on body weight or adiposity. Body weight was 
comparable between HFD-fed alb-crePtp1b-/- and HFD-fed Ptp1bfl/fl control female mice 
throughout the study (Figure 1A), as previously reported in male mice [7]. There was ~50% 
decrease in PTP1B protein levels in whole liver lysates (Figure 1B). Furthermore, body weight, 
adiposity and bone mineral density were comparable between chow-fed alb-crePtp1b-/- and 
Ptp1bfl/fl control mice (Figure 1C, D and E), as assessed by dual-energy X-ray absorptiometry 
(DXA). 
 
 
Liver-PTP1B deletion increases JAK2 and mTOR but not STAT phosphorylation in mice 
on chow diet in the fasted state. 
To assess whether liver-PTP1B deletion attenuated growth hormone-mediated JAK- 
STAT phosphorylation, chow-fed alb-crePtp1b-/- and Ptp1bfl/fl control mice, fasted for a period 
of 48-hours to induce GH resistance, were injected intraperitoneally with hGH for 5 or 10 min. 
hGH stimulation significantly increased JAK2 phosphorylation at both 5 and 10 min in 
both groups (Figure 2A and B). However, JAK2 phosphorylation was significantly higher   in 
 
alb-crePtp1b-/-  mice compared to Ptp1bfl/fl control mice at 10 min (Figure 2A and B). 
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While hGH stimulation increased STAT5 phosphorylation at both 5 and 10 min post- 
GH stimulation, there were no differences between the two groups (Figure 2A and C). STAT3 
phosphorylation was also comparable between groups at all time points (Figure 2A and D). 
hGH stimulation significantly increased mTOR phosphorylation at 5 and 10 min in both 
groups, with alb-crePtp1b-/- mice displaying significantly higher phosphorylation than 
Ptp1bfl/fl control mice at the 5 min time point (Figure 2A, F and G). 
ERK1/2 and S6 phosphorylation was comparable between groups at all time points 
examined (Figure 2A, E). 
 
 
Liver-PTP1B deletion increases SOCS3 gene expression at 30 min post-hGH stimulation 
following a 48-hour fast. 
As expected from previous studies, hGH stimulation significantly increased gene 
expression of SOCS2 and SOCS3 at 90 min. 
SOCS3 gene expression was significantly increased in alb-crePtp1b-/- at 30-min post- 
GH stimulation (two-tailed t-test; p=0.047), while at 90-min post-GH stimulation this was no 
longer significant (two-tailed t-test p=0.07). 
There were no significant differences in SOCS2 expression levels between alb- 
crePtp1b-/-  mice Ptp1bfl/fl control mice (Figure 3A and B). 
 
 
Liver-PTP1B deletion results in a small but significant effect on STAT5 phosphorylation 
in response to growth hormone (GH) stimulation. 
To assess the role of liver-PTP1B deficiency in growth hormone signalling under 
diabetic, insulin-resistant conditions, alb-crePtp1b-/- and Ptp1bfl/fl control mice were fed HFD 
for 32 weeks and then injected with hGH for 30 min under ad lib fed or 48-hour fasted 
conditions (to induce GH resistance). 
8  
Interestingly, under ad lib HFD-fed conditions, hGH-stimulation was not able to 
significantly increase STAT3 phosphorylation in alb-crePtp1b-/- or Ptp1bfl/fl control mice 
(Figure 4B, D) but it did robustly increase STAT3 phosphorylation under 48-hour fasted 
conditions in control mice (Figure 4F and H). 
hGH robustly stimulated STAT5 phosphorylation under chow 48-hour-fasted 
conditions in both groups of mice. However, under HFD conditions, a significant increase in 
STAT5 was only observed in alb-crePtp1b-/- ad lib HFD-fed mice (Figure 4C, D, G and H). 
 
 
Discussion 
 
PTP1B has previously been shown to attenuate growth hormone (GH)-mediated JAK-STAT 
signalling in hGH-treated fibroblasts and in livers from male globally-deficient PTP1B 
knockout mice [6]. In order to determine liver-PTP1B specificity of the previously published 
data [6], JAK-STAT signalling was assessed in female chow- and HFD-fed liver-specific 
knockout mice following a hGH stimulation time course under ad lib fed and 48-hour fasted 
states (to induce GH-resistance). 
As with other mouse models of PTP1B-specific deletion [7, 10, 11] body weight, body fat and 
bone mineral density of the female liver-specific PTP1B knockout mice did not differ from 
control mice. This is the first examination of the body weight phenotype in liver-specific 
PTP1B knockout animals in females and reveals that there is no sexual dimorphism in body 
weight regulation in these animals. 
In our studies, hGH led to a robust stimulation of the JAK-STAT signalling pathway, as 
expected. Interestingly however, HFD-feeding resulted in an inability of hGH-stimulation to 
induce phosphorylation of STAT3 under fed conditions. In agreement with previous studies, 
we observed higher JAK2 phosphorylation with liver-PTP1B deletion after 10 min of hGH 
stimulation under chow feeding conditions. PTP1B was previously shown to be    recruited to 
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JAK2 in 293-LA cells in response to GH [6]. While we did not observe effects on STAT3 
phosphorylation in liver-PTP1B knockout mice, hGH did robustly stimulate and significantly 
increase STAT5 phosphorylation under both fed and fasted conditions, in alb-crePtp1b-/- mice. 
STAT5a and STAT5b have been suggested to be direct PTP1B substrates [12]. 
A previous study observed that the abundance of SOCS2 mRNA, but not SOCS3 mRNA, 
was increased 90 min after hGH stimulation in global Ptp1b-/- mouse livers relative to controls. 
In the present study, hGH led to an increase in both SOCS2 and SOCS3 gene expression in both 
groups of mice after 90 min of hGH stimulation. However, only SOCS3 expression was 
significantly higher after 30 min of hGH stimulation in the livers of alb-crePtp1b-/- mice 
compared to Ptp1bfl/fl mice, while SOCS2 remained unchanged. Expression of SOCS3, an early 
response GH-target gene, has been found to closely mimic the effects of GH on STAT5 
phosphorylation in mice [14]. The previously observed effects of GH on SOCS2 and SOCS3 
gene expression in livers from global Ptp1b-/- mice are somewhat inconsistent with our 
findings. It may be that a degree of tissue cross-talk is responsible for some of the signalling 
changes previously observed in the global Ptp1b-/- mice. Furthermore, age-related differences 
could have contributed to the contrary results. The previous study used young 9–10 week old 
mice, whereas our mice were 6-12 months old and were therefore fully developed. 
Recently, novel GH-mediated sites were identified in 3T3-F442A preadipocytes by 
quantitative phosphoproteomics. 228 phosphosites in 141 proteins that exhibited rapid (5 or 15 
min) GH-dependant significant increases or decreases in phosphorylation were identified [13]. 
Several of the GH-stimulated phosphorylation sites were known (e.g. T203/Y205 in murine 
ERK1 and T183/Y185 in murine ERK2; Y694 and Y699 in STAT5a and STAT5b, 
respectively; S939 in tuberous sclerosis protein 2). The remaining 126 GH-stimulated sites that 
were identified were not previously associated with GH. A number of these newly identified 
sites were amongst insulin and mTOR signalling pathways. In the current study, mTOR 
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phosphorylation, but not S6 or ERK1/2 phosphorylation, was significantly increased following 
hGH stimulation at 5 and 10 min in both groups of mice. hGH-stimulated mTOR 
phosphorylation was significantly higher with liver-PTP1B deletion compared to controls, 
revealing this part of the pathway under direct control of PTP1B. 
Overall, liver-specific PTP1B deletion leads to significant changes in GH signalling and 
phosphorylation of JAK2, STAT5 and mTOR, revealing a direct role for hepatic-PTP1B in 
regulation of these signalling processes. 
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Figure Legends 
Figure 1. PTP1B deletion has no effect on body weight, adiposity or bone mineral density. 
A: Body weight of Ptp1bfl/fl mice (n = 9) and alb-crePtp1b-/- mice (n = 14) on HFD. B: PTP1B 
deletion immunoblot and quantification of Ptp1bfl/fl mice (n = 4) and alb-crePtp1b-/- mice (n = 
4) on HFD. C: Body fat vs. body weight of Ptp1bfl/fl mice (n = 7) and alb-crePtp1b-/- mice (n = 
 
10) on a chow diet. D: Body fat percentage of Ptp1bfl/fl mice (n = 7) and alb-crePtp1b-/- mice 
(n = 10) on a chow diet. E: Bone mineral density of Ptp1bfl/fl mice (n = 7) and alb-crePtp1b-/- 
mice (n = 10) on a chow diet. Groups are indicated in the figures, with Ptp1bfl/fl mice in open 
circles/white bars and alb-crePtp1b-/- mice in closed circles/black bars. Data are represented as 
mean ± SEM; data were analysed using repeated measures two-way ANOVA with Bonferroni 
multiple comparisons post-tests or two-tailed Student’s t-test (*P < 0.05). 
 
 
Figure 2. Effects of liver-PTP1B deletion on growth-hormone induced phosphorylation of 
JAK2, STAT5, STAT3, S6 and mTOR. B: pJAK2, pSTAT5, pSTAT3, pS6 and p-mTOR 
immunoblots. Total proteins were used as loading controls. B: pJAK2 immunoblot 
quantification. C: pSTAT5 immunoblot quantification. D: pSTAT3 immunoblot 
quantification. E: pS6 immunoblot quantification. F: p-mTOR immunoblot quantification. G: 
p-mTOR immunoblot quantification to total mTOR. Groups and hGH stimulation time course 
are indicated in the figures. Ptp1bfl/fl mice 0 min (n = 2), 5 min (n = 3), 10 min (n = 3) and alb- 
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crePtp1b-/- mice 0 min (n = 2), 5 min (n = 3), 10 min (n = 4). Ptp1bfl/fl mice are indicated by 
white bars and alb-crePtp1b-/- mice by black bars. Data are represented as mean ± SEM; data 
were analysed using one-way ANOVA with Tukey’s multiple comparison post tests or two- 
tailed Student’s t-test (*P < 0.05). 
 
 
Figure 3. Effects of liver-PTP1B deletion on SOCS2 and SOCS3 gene expression after 48- 
hour fasting. A: SOCS2 fasted gene expression in mice on HFD. B: SOCS3 fasted gene 
expression in mice on HFD. Hprt was used as a reference gene. Groups and hGH stimulation 
time course are indicated in the figures. Ptp1bfl/fl mice 0 min (n = 2), 30 min (n = 3), 90 min (n 
= 4) and alb-crePtp1b-/-  mice 0 min (n = 3), 30 min (n = 5), 90 min (n = 6). Ptp1bfl/fl mice  are 
 
indicated by white bars and alb-crePtp1b-/-  mice by black bars. Data are represented as  mean 
 
± SEM; data were analysed using one-way ANOVA with Tukey’s multiple comparison post 
tests or two-tailed Student’s t-test (*P < 0.05). 
 
 
Figure 4. Effects of Liver-PTP1B deletion on JAK/STAT phosphorylation under ad lib fed 
and 48-hour fasted diabetic conditions. A: pJAK2 fed immunoblot quantification. B: 
pSTAT3 fed immunoblot quantification. C: pSTAT5 fed immunoblot quantification. D: 
pJAK2, pSTAT3 and pSTAT5 fed immunoblot. Total proteins were used as loading controls. 
Groups and hGH stimulation time course are indicated in the figures. Ptp1bfl/fl mice 0 min (n = 
3), 30 min (n = 3) and alb-crePtp1b-/- mice 0 min (n = 4), 30 min (n = 4). E: pJAK2 fasted 
immunoblot quantification. F: pSTAT3 fasted immunoblot quantification. G: pSTAT5 fasted 
immunoblot quantification. H: pJAK2, pSTAT3 and pSTAT5 fasted immunoblot. Total 
proteins were used as loading controls. Groups and hGH stimulation time course are indicated 
in the figures. Ptp1bfl/fl mice 0 min (n = 2), 30 min (n = 3) and alb-crePtp1b-/- mice 0 min (n = 
3), 30 min (n = 5). Ptp1bfl/fl mice are indicated by white bars and alb-crePtp1b-/- mice by black 
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bars. Data are represented as mean ± SEM; data were analysed using one-way ANOVA with 
Tukey’s multiple comparison post tests or two-tailed Student’s t-test (*P < 0.05). 
